Holen Sie sich die Stockscreener-App
1.814
1.95%
-0.036
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SLS?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1.85
Offen:
$1.89
24-Stunden-Volumen:
925.87K
Relative Volume:
0.33
Marktkapitalisierung:
$191.64M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-37.34M
KGV:
-1.3338
EPS:
-1.36
Netto-Cashflow:
$-36.91M
1W Leistung:
+17.03%
1M Leistung:
-1.95%
6M Leistung:
+42.83%
1J Leistung:
+38.47%
1-Tages-Spanne:
$1.80
$1.8971
1-Wochen-Bereich:
$1.53
$1.8971
52-Wochen-Spanne:
$0.772
$2.2691
Sellas Life Sciences Group Inc Stock (SLS) Company Profile
Firmenname
Sellas Life Sciences Group Inc
Sektor
Branche
Telefon
(646) 200-5278
Adresse
7 TIMES SQUARE, NEW YORK, NY
Vergleichen Sie SLS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SLS
Sellas Life Sciences Group Inc
|
1.82 | 182.16M | 0 | -37.34M | -36.91M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
604.87 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.72 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
667.34 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
310.73 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Sellas Life Sciences Group Inc Stock (SLS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-07-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-11-01 | Eingeleitet | Oppenheimer | Outperform |
| 2018-04-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-19 | Hochstufung | Maxim Group | Hold → Buy |
Sellas Life Sciences Group Inc Aktie (SLS) Neueste Nachrichten
SELLAS Life Sciences’ Triumphant Advances - StocksToTrade
Sellas Life Sciences: SLS009’s Phase 2 Sets Up A Promising 2026 (NASDAQ:SLS) - Seeking Alpha
SELLAS Life Sciences Rises On Cancer Trial Progress And New Listings - Finimize
What’s the fair value of SELLAS Life Sciences Group Inc. stockEarnings Recap Summary & Low Drawdown Momentum Ideas - mustnews.co.kr
Published on: 2025-08-15 06:21:10 - beatles.ru
Chart Patterns Forming a Bullish Setup in SELLAS Life Sciences Group Inc.2025 Technical Patterns & Real-Time Volume Trigger Notifications - beatles.ru
Optimistic Buy Rating for SELLAS Life Sciences Group Driven by Promising Trial Results and Financial Stability - TipRanks
Sellas Life Sciences Reports Q2 2025 Financial Results - TipRanks
Sellas Life Sciences Group Inc reports results for the quarter ended June 30Earnings Summary - TradingView
SELLAS Life Sciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Sellas Life Sciences' GPS Trial Continues with Positive IDMC Recommendation - AInvest
SELLAS Life Sciences Receives Positive IDMC Recommendation to Continue Phase 3 REGAL Trial of GPS in AML. - AInvest
Sellas Life Sciences Group Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView
SELLAS Life Sciences Announces Independent Data Monitoring Committee Periodic Review and Positive Recommendation to Continue Pivotal Phase 3 Regal Trial of GPS in AML Without Modification - MarketScreener
SELLAS Life Sciences Gets Positive IDMC Nod To Continue Phase 3 Trial Of AML Treatment - Nasdaq
SELLAS Life Sciences Announces Independent Data Monitoring Committee Periodic Review and Positive Recommendation to Continue Pivotal Phase 3 REGAL Trial of GPS in AML Without Modification - The Manila Times
IDMC recommends continuation of Phase 3 AML trial for galinpepimut-S - Investing.com India
SELLAS Life Sciences Announces Independent Data Monitoring - GlobeNewswire
SELLAS Phase 3 Cancer Drug GPS Clears Critical Safety Review, Final Data Expected This Year - Stock Titan
SELLAS Life Sciences Group Inc. Consolidation Zone May Signal AccumulationMulti-Bagger Potential Stock Forecast Tools Released - metal.it
What institutional investors are buying SELLAS Life Sciences Group Inc. stockGet alerts on top growth stocks daily - Jammu Links News
What analysts say about SELLAS Life Sciences Group Inc. stockDiscover investment plans that deliver results - Jammu Links News
What is the risk reward ratio of investing in SELLAS Life Sciences Group Inc. stockBuild a portfolio for long-term financial success - Jammu Links News
Does SELLAS Life Sciences Group Inc. stock perform well during market downturnsExceptional profit velocity - Jammu Links News
How does SELLAS Life Sciences Group Inc. compare to its industry peersBreakout stock performance - Jammu Links News
What are the latest earnings results for SELLAS Life Sciences Group Inc.Achieve fast wealth growth with smart picks - Jammu Links News
What are analysts’ price targets for SELLAS Life Sciences Group Inc. in the next 12 monthsRapid profit acceleration - Jammu Links News
What makes SELLAS Life Sciences Group Inc. stock price move sharplyGet professional advice for portfolio optimization - Jammu Links News
What are SELLAS Life Sciences Group Inc. company’s key revenue driversInvest smarter with daily stock recommendations - Jammu Links News
SELLAS Life Sciences Group (SLS) Upgraded to Buy: What Does It Mean for the Stock? (Revised) - MSN
What is the dividend policy of SELLAS Life Sciences Group Inc. stockRetirement Planning Watchlist For Every Investor - Jammu Links News
SELLAS Life Sciences : Corporate PresentationAugust 2025 - MarketScreener
What catalysts could drive SELLAS Life Sciences Group Inc. stock higher in 2025Wealth Building Trend Scanner For Smart Trading - Jammu Links News
Published on: 2025-07-31 14:02:06 - beatles.ru
Sector Leaders Rotate Capital Into SELLAS Life Sciences Group Inc.Stock Screener With Smart Filters Highlights Top Picks - beatles.ru
Published on: 2025-07-29 08:30:26 - metal.it
What risks could impact SELLAS Life Sciences Group Inc. stock performanceIntraday Trend Analysis for Fast Gains Released - beatles.ru
Should I hold or sell SELLAS Life Sciences Group Inc. stock in 2025Market Forecast Updates That Work - Jammu Links News
How strong is SELLAS Life Sciences Group Inc. company’s balance sheetFree Technical Analysis Support - jammulinksnews.com
How Resilient Is SELLAS Life Sciences Group Inc. Stock During Economic DownturnsTop Performer Shortlist - metal.it
SELLAS Life Sciences Group Inc. Stock Analysis and ForecastTriple-digit profit margins - PrintWeekIndia
What institutions are buying SELLAS Life Sciences Group Inc. stock nowStrong return on assets - Jammu Links News
What drives SELLAS Life Sciences Group Inc. stock priceUnprecedented growth rates - PrintWeekIndia
Is SELLAS Life Sciences Group Inc. a good long term investmentExceptional profit potential - PrintWeekIndia
Finanzdaten der Sellas Life Sciences Group Inc-Aktie (SLS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sellas Life Sciences Group Inc-Aktie (SLS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Wasman Jane | Director |
May 30 '25 |
Buy |
1.69 |
20,000 |
33,800 |
30,400 |
| Kalin Katherine Bach | Director |
May 22 '25 |
Buy |
1.80 |
20,000 |
36,000 |
41,000 |
0.88%
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):